Tendersinfo keep you informed about the latest events in the national and international Procurement Industry. Procurement News provides in-depth coverage of the procurement industry, including contract awards, contract additions, new contract wins, mergers and acquisitions. Tendersinfo through its tender news section provides an update on all domestic and global tendering opportunities, invitation to bid & trade leads.

Publish Date : 14-Jan-2014

A contract is signed by Median Technologies with a San Francisco-area based biotech company. The contract is worth €384,000 (eq. $524,500).

Median Technologies will offer imaging services to support a phase II clinical trial for advanced non-small cell lung cancer. Within the framework of the study, imaging data will be purchased from 90 clinical sites, based in 12 European countries, in the US, and in Canada.

Expected total enrollment is 440 patients with a "first patient in" forecasted May, 2014. Median will provide a set of services comprising clinical site qualification and training, as well as image and data collection, quality control, and storage.

Ciaran Cooper, head of Business Development, Clinical Trials Imaging, North America said, "We are pleased to start 2014 supporting this important trial for a new, hypoxia-targeted therapy". "Adding this new biotech client demonstrates that our imaging services bring value not only to major pharmaceutical companies, but to top biotechnology companies as well."

Median Technologies is a service provider for image interpretation and management in oncology clinical trials.

Go to previous page